Testing effectiveness (Phase 2)Study completedNCT00595101
What this trial is testing
A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension.
Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Bausch & Lomb Incorporated 117